HGHao Geng

Hao Geng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hao Geng has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Dongdong Tang

    Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China

    5 shared publications
  • Chuan Xu

    Reproductive Medicine Center, Department of Obstetrics and Gynecology The First Affiliated Hospital of Anhui Medical University Hefei China

    3 shared publications
  • Xiaojin He

    Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

    3 shared publications
  • Hui Yu

    Reproductive Medicine Center, Department of Obstetrics and Gynecology The First Affiliated Hospital of Anhui Medical University Hefei China

    2 shared publications
  • Zhaofeng Liang

    Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213017, P.R. China

    2 shared publications
  • Baoyan Wu

    Reproductive Medicine Center, Department of Obstetrics and Gynecology The First Affiliated Hospital of Anhui Medical University Hefei China

    1 shared publication

Latest Publications

  • Ballelic Variants of TTC ‐Related Genes Cause Asthenoteratozoospermia With Favorable Clinical Outcomes After ICSI

    by Hui Yu, Dongdong Tang, Jiajun Fang, Meng Gu, Kuokuo Li, Zhicong Chen, Baoyan Wu, Xueping Liu, Hao Geng, Lewen Ruan, et al.

    Background: Male infertility is a complex, multifactorial disorder that affects ∼7% of men worldwide. Variants in DNAH and CFAP genes are well‐established causes of asthenoteratozoospermia, but the contribution of TTC ‐family genes ( TTC12 , TTC21A , TTC29 ) to sperm dysfunction and ICSI outcome remains poorly documented. Objectives: To investigate the genetic and clinical implications of TTC gene variants in men with asthenoteratozoospermia and to evaluate the ICSI outcomes of affected individuals. Materials and Methods: We performed whole‐exome sequencing and bioinformatic filtering in 843 men with asthenoteratozoospermia. Candidate variants were validated by Sanger sequencing, and the effects on protein expression were assessed using western blotting and immunofluorescence. Sperm morphology and ultrastructure were examined by light and transmission electron microscopy. Clinical outcomes were evaluated following ICSI treatment, including a total of 18 TTC ‐variant patients and DNAH1 ‐variant men. Results: Thirteen TTC variants in 11 unrelated patients (1.3%) were identified in this cohort, including two homozygous TTC12 variants, six homozygous plus two compound‐heterozygous TTC21A variants, and one homozygous TTC29 variants. Variants induced markedly reduced TTC proteins expression and disorganized axonemes and peri‐axonemal structures. Clinical data from ICSI cycles demonstrated that fertilization could be achieved, importantly the first reported live birth for TTC21A variants, although blastocyst rates were lower than in DNAH1 ‐mutated controls. Conclusion: This study not only expanded the genotype–phenotype spectrum of variations in the TTC gene family, but also built a bridge between molecular genetics and clinical application, demonstrating the translational path from gene discovery to effective treatment.

  • Bi-allelic variants in chromatoid body protein TDRD6 cause spermiogenesis defects and severe oligoasthenoteratozoospermia in humans

    by Rui Guo, Huan Wu, Xiaoyu Zhu, Guanxiong Wang, Kaiqin Hu, Kuokuo Li, Hao Geng, Chuan Xu, Chenwan Zu, Yang Gao, et al.

    Background: The association between the TDRD6 variants and human infertility remains unclear, as only one homozygous missense variant of TDRD6 was found to be associated with oligoasthenoteratozoospermia (OAT). Methods: Whole-exome sequencing and Sanger sequencing were employed to identify potential pathogenic variants of TDRD6 in infertile men. Histology, immunofluorescence, immunoblotting and ultrastructural analyses were conducted to clarify the structural and functional abnormalities of sperm in mutated patients. Tdrd6-knockout mice were generated using the CRISPR–Cas9 system. Total RNA-seq and single-cell RNA-seq (scRNA-seq) analyses were used to elucidate the underlying molecular mechanisms, followed by validation through quantitative RT-PCR and immunostaining. Intracytoplasmic sperm injection (ICSI) was also used to assess the efficacy of clinical treatment. Results: Bi-allelic TDRD6 variants were identified in five unrelated Chinese individuals with OAT, including homozygous loss-of-function variants in two consanguineous families. Notably, besides reduced concentrations and impaired motility, a significant occurrence of acrosomal hypoplasia was detected in multiple spermatozoa among five patients. Using the Tdrd6-deficient mice, we further elucidate the pivotal role of TDRD6 in spermiogenesis and acrosome identified. In addition, the mislocalisation of crucial chromatoid body components DDX4 (MVH) and UPF1 was also observed in round spermatids from patients harbouring TDRD6 variants. ScRNA-seq analysis of germ cells from a patient with TDRD6 variants revealed that TDRD6 regulates mRNA metabolism processes involved in spermatid differentiation and cytoplasmic translation. Conclusion: Our findings strongly suggest that TDRD6 plays a conserved role in spermiogenesis and confirms the causal relationship between TDRD6 variants and human OAT. Additionally, this study highlights the unfavourable ICSI outcomes in individuals with bi-allelic TDRD6 variants, providing insights for potential clinical treatment strategies.


  • Open Access

    A patient with 47, XYY mosaic karyotype and congenital absence of bilateral vas deferens: a case report and literature review

    by Ci Zou, Dexin Yu, Hao Geng, Xiaofeng Lan, Wei Sun

    The incidence of 47, XYY syndrome in live-born male infants is 1/1000. Due to its variable clinical symptoms, the diagnosis is easy to miss. The incidence of congenital bilateral absence of the vas deferens (CBAVD) in infertile men is 1–2%. The main cause is the mutation of CFTR and ADGAG2 genes. The patient was a 33-year-old man who visited a doctor 5 years ago due to infertility. The investigation revealed that the patient’s secondary sexual characteristics, testicular, and penis development were normal, and there was no gynecomastia, but the bilateral vas deferens and epididymis were not palpable. Transrectal ultrasound showed that the left seminal vesicle was missing, and the right seminal vesicle was atrophied. No abnormality was observed in Y chromosome microdeletion. Karyotype analysis indicated that the patient was 46, XY/47, XYY mosaic. Genetic testing found heterozygous mutations at two sites of CFTR (c263T > G and c2249C > T). Herein, we report the rare case of a male patient with clinical manifestations of infertility, chromosome 46, XY/47, XXY mosaic type, simultaneously manifested as the absence of bilateral vas deferens. Two pathogenic heterozygous CFTR gene mutations were found. Given the low genetic risk of the disease, we recommend that patients undergo intracytoplasmic sperm injection (ICSI) for fertility assessment.


  • Association between the international index of erectile function‐15 and female sexual function index in Chinese infertile couples

    by Qiushuang Wang, Hao Geng, Caiyun Lu, Zonglan Jin, Chuan Xu, Dongdong Tang

    Infertility has a detrimental impact on the sexual function of involuntarily childless couples. However, the effect of male sexual function on female partner's sexual function in infertile couples remains unknown. In order to explore the association between these couples' sexual function, 324 consecutive couples with infertility and 326 female-age-matched fertile couples were enrolled in this study. The female sexual function index (FSFI) and sexual history were evaluated in female partners. In addition to the international index of erectile function-15 (IIEF-15) and sexual history, self-reported intravaginal ejaculation latency time was evaluated in male partners. The demographics and depression status of couples were also recorded. We observed a higher occurrence of female sexual dysfunction (FSD) in infertile females than in fertile females (58.6% vs. 50.3%, p = 0.033). FSD was associated with a number of risk variables, including partner's erectile dysfunction (ED), depression and sexual frequency. The overall FSFI score was positively associated with the IIEF-15 score (r = 0.347, p < 0.001). Besides, six FSFI domains were positively correlated with five IIEF-15 domains (p < 0.05). In conclusion, it is critical to assess and address FSD as well as the sexual problems in male partners in infertile couples.


  • Open Access

    Biallelic Variants in CCDC39 Gene Lead to Primary Ciliary Dyskinesia and Kartagener Syndrome

    by Xiao Shi, Hao Geng, Hui Yu, Xiaolong Hu, Guanxiong Wang, Jin Yang, Hui Zhao

    Background. Primary ciliary dyskinesia (PCD) is a clinical syndrome characterized by cilia with an abnormal structure or function. Its main clinical manifestations comprise chronic bronchitis, cough, recurrent respiratory infections, situs inversus, and male infertility. Single‐gene variants are widely assumed to be the main cause of this rare disease, and more than 40 genes have been described to be associated with its onset. CCDC39 is essential for assembling the inner dynein arms and dynein regulatory complex and is important in cilia motility. CCDC39 variants were reported as a monogenic etiology of PCD. Methods. This study investigated two unrelated Chinese patients diagnosed as PCD. The chest computed tomography scan was performed to identify PCD phenotypes of the two probands. Considering the effect of PCD on male fertility, routine semen analysis, sperm morphology examination, and scanning electron microscopy were performed to assess the semen characteristics of male proband in family 2 (F2 II‐1), who had a history of infertility. Subsequently, the peripheral blood samples of probands were collected to perform whole‐exome sequencing (WES) to explore the possible genetic causes of this disease. Results. Whole‐exome sequencing revealed a homozygous CCDC39 variant in the female proband of family 1 (F1 II‐1: c.286C>T:p.Arg96Ter) and two compound heterozygous CCDC39 variants in the male proband of family 2 (F2 II‐1: c.732_733del: p.Ala245PhefsTer18; c.2800_2802dup:p.Val934dup). The two probands showed the typical PCD phenotypes, including chronic bronchitis, recurrent respiratory infections, and situs inversus. The male proband also showed oligoasthenoteratospermia with multiple morphological abnormalities of the sperm flagella. Additionally, CCDC39 protein level was significantly lower in the sperm of male proband than in the sperm from normal controls. Conclusion. We identified a homozygous variant reported previously and two compound heterozygous variants of CCDC39 possibly responsible for PCD pathogenesis, expanding the variant spectrum of Chinese PCD, Kartagener syndrome, and morphological abnormalities of the sperm flagella involving CCDC39.


  • Open Access

    Exosomes in bladder cancer: novel biomarkers and targets

    by Hao Geng, Qingchen Zhou, Wenhao Guo, Ling Lu, Liangkuan Bi, Yi Wang, Jie Min, Dexin Yu, Zhaofeng Liang

    Exosomes are nanometer-sized vesicles that contain various types of biologically active components, including proteins, nucleic acids, carbohydrates, and l


  • Open Access

    Identifying Sequence Variants of 18 Hereditary Ovarian Cancer‐Associated Genes in Chinese Epithelial Ovarian Cancer Patients

    by Xiao Wu, Zhengzheng Chen, Pingping Ren, Xuxu Zhao, Dongdong Tang, Hao Geng, Xiaofeng Xu, Weidong Zhao

    Objectives. The causes of ovarian cancer (OC) have been confirmed to be closely related to genetic factors. Identifying sequence variants of hereditary ovarian cancer (HOC) susceptibility genes can increase clinical surveillance, facilitate early detection, and provide personalized treatment for patients. This study is aimed at investigating the variation frequency of HOC susceptibility genes in the Chinese population and providing information for the etiology and genetics of OC. Methods. 118 epithelial OC patients were recruited in this clinical study. Variants of 18‐gene panel were detected in blood samples by next‐generation sequencing (NGS) technology. Results. Overall, 36.44% (43/118) of patients carried at least one pathogenic variant. Among these, BRCA1 pathogenic variants were detected in 31 (26.27%) patients, and 5 (4.24%) patients carried pathogenic variants of BRCA2. Moreover, 27.12% (32/118) of patients carried variants of unknown significance (VUSs). Importantly, we detected eight variants that were not reported previously. Conclusions. Our study enlarged the spectrum of HOC‐associated gene sequence variants in the Chinese population and also proved the necessity of multigene testing in epithelial OC patients. The identification of patients with HOC will allow family members to undergo cascade testing where identification of unaffected carriers can facilitate early detection, risk reduction, or prevention of OC and ultimately improve long‐term outcomes.


  • Open Access

    A Novel Missense Variant of TP63 Heterozygously Present in Split‐Hand/Foot Malformation

    by Hao Geng, Dongdong Tang, Chuan Xu, Xiaojin He, Zhiguo Zhang

    Background. Split‐hand/foot malformation (SHFM) is a severe congenital disability mainly characterized by the absence or hypoplasia of the central ray of the hand/foot. To date, several candidate genes associated with SHFM have been identified, including TP63, DLX5, DLX6, FGFR1, and WNT10B. Herein, we report a novel variant of TP63 heterozygously present in affected members of a family with SHFM. Methods. This study investigated a Chinese family, in which the proband and his son suffered from SHFM. The peripheral blood sample of the proband was used to perform whole‐exome sequencing (WES) to explore the possible genetic causes of this disease. Postsequencing bioinformatic analyses and Sanger sequencing were conducted to verify the identified variants and parental origins on all family members in the pedigree. Results. By postsequencing bioinformatic analyses and Sanger sequencing, we identified a novel missense variant (NM_003722.4:c.948G>A; p.Met316Ile) of TP63 in this family that results in a substitution of methionine with isoleucine, which is probably associated with the occurrence of SHFM. Conclusion. A novel missense variant (NM_003722.4:c.948G>A; p.Met316Ile) of TP63 in SHFM was thus identified, which may enlarge the spectrum of known TP63 variants and also provide new approaches for genetic counselling of families with SHFM.


  • Open Access

    ERK5 regulates tobacco smoke-induced urocystic epithelial-mesenchymal transition in BALB/c mice

    by Jie Min, Hao Geng, Zhiqi Liu, Zhaofeng Liang, Zhiqiang Zhang, Dongdong Xie, Yi Wang, Tao Zhang, Dexin Yu, Caiyun Zhong

    Tobacco smoke (TS) is an important risk factor of bladder cancer. Epithelial‑mesenchymal transition (EMT) is involved in the initiation and development of cancer. The role of extracellular signal‑regulated kinase (ERK) 5 in regulating TS‑induced EMT remains to be elucidated. The aim of the present study was to investigate the regulatory role of ERK5 in TS‑triggered EMT in the bladder of mice. BALB/c mice were used for an in vivo TS exposure model. Mice were treated for 6 h a day for 12 weeks. The results demonstrated that mice exposed to TS had decreased mRNA and protein expression levels of the epithelial markers E‑cadherin and zonula occludens‑1, whereas expression levels of the mesenchymal markers Vimentin and N‑cadherin were increased. Treatment with XMD8‑92, a highly specific ERK5 inhibitor, effectively abrogated TS‑triggered activation of ERK5, activator protein‑1 and EMT alterations in the bladder of BALB/c mice. The data suggested that ERK5 regulates TS‑mediated urocystic EMT. These findings provide insight into the molecular mechanisms of TS‑associated bladder tumorigenesis.